Asset Management One
IRWD icon

Asset Management One’s Ironwood Pharmaceuticals IRWD Stock Holding History

Asset Management One’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-743,503
Closed -$9.59M – 1096
2016
Q3 		$9.59M Sell
743,503
-211,400
-22% -$2.47M 0.14% 160
2016
Q2 		$10.4M Sell
954,903
-43,842
-4% -$428K 0.16% 150
2016
Q1 		$8.76M Buy
998,745
+12,712
+1% +$105K 0.13% 172
2015
Q4 		$9.96M Sell
986,033
-26,178
-3% -$253K 0.15% 161
2015
Q3 		$8.33M Sell
1,012,211
-131,314
-11% -$1.23M 0.13% 197
2015
Q2 		$11.1M Sell
1,143,525
-238,444
-17% -$2.77M 0.15% 162
2015
Q1 		$19.1M Sell
1,381,969
-1,883
-0.1% -$24.7K 0.24% 96
2014
Q4 		$17.3M Buy
1,383,852
+318,738
+30% +$3.65M 0.23% 101
2014
Q3 		$11.9M Buy
+1,065,114
New +$12.2M 0.16% 143

Other funds holding IRWD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Asset Management One's IRWD Position: Q4 2016 in Review

Asset Management One sold out of Ironwood Pharmaceuticals (IRWD) in Q4 2016, closing a stake of 743,503 shares — an estimated $9.59M sold.

Asset Management One first reported a position in IRWD in Q3 2014 and held it in 9 quarters. The position peaked at $19.1M in Q1 2015. 163 funds tracked by Wall St. Rank hold IRWD as of Q4 2016.

  • Asset Management One reported no remaining Ironwood Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
  • Asset Management One sold 743,503 Ironwood Pharmaceuticals shares in Q4 2016, an estimated $9.59M.
  • Asset Management One first reported a position in Ironwood Pharmaceuticals in Q3 2014 and held it in 9 quarters.
  • Asset Management One's Ironwood Pharmaceuticals position peaked at $19.1M in Q1 2015.
  • 163 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q4 2016.

Based on Asset Management One's 13F filing for Q4 2016, filed 13 Feb 2017.